SWP
INDP icon

Stratos Wealth Partners’s Indaptus Therapeutics INDP Stock Holding History

Stratos Wealth Partners’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-958
Closed -$38.9K – 1171
2022
Q4 		$38.9K Hold
958
– – ﹤0.01% 1121
2022
Q3 		$58K Hold
958
– – ﹤0.01% 1092
2022
Q2 		$70K Sell
958
-41,483
-98% -$3.24M ﹤0.01% 1149
2022
Q1 		$4.75M Sell
42,441
-7,143
-14% -$917K 0.11% 197
2021
Q4 		$7.91M Buy
+49,584
New +$9.21M 0.18% 119

Other funds holding INDP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return
SAM
Strategy Asset Managers Pasadena, California $670M AUM 34.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Stratos Wealth Partners's INDP Position: Q1 2023 in Review

Stratos Wealth Partners sold out of Indaptus Therapeutics (INDP) in Q1 2023, closing a stake of 958 shares — an estimated $38.9K sold.

Stratos Wealth Partners first reported a position in INDP in Q4 2021 and held it in 5 quarters. The position peaked at $7.91M in Q4 2021. 14 funds tracked by Wall St. Rank hold INDP as of Q1 2023.

  • Stratos Wealth Partners reported no remaining Indaptus Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Stratos Wealth Partners sold 958 Indaptus Therapeutics shares in Q1 2023, an estimated $38.9K.
  • Stratos Wealth Partners first reported a position in Indaptus Therapeutics in Q4 2021 and held it in 5 quarters.
  • Stratos Wealth Partners's Indaptus Therapeutics position peaked at $7.91M in Q4 2021.
  • 14 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q1 2023.

Based on Stratos Wealth Partners's 13F filing for Q1 2023, filed 27 Apr 2023.